Coldrex laryplus

Coldrex laryplus Medicine

Top 20 drugs with the same components:

Contraindications

Hypersensitivity to dyclonine hydrochloride.

Undesirable effects

Extremely rare-irritation of the oral cavity, disorders of the gastrointestinal tract (nausea, diarrhea), numbness of the oral mucosa and changes in taste.

Special instructions

Excessive or prolonged use can cause temporary numbness of the oral and pharyngeal mucosa, which increases the risk of biting the tongue (or cheek mucosa) and weakens the gag reflex.

Therapeutic indications

For the symptomatic treatment of pain, inflammation, moderate irritation in the mouth and pharynx.

Pharmacotherapeutic group

  • Local anesthetics

Special precautions for storage

At a temperature not exceeding 25 °C.

Keep out of reach of children.

The shelf life of the drug Coldrex® LariPlus3 года.

Do not use after the expiration date indicated on the package.

Nature and contents of container

1 cherry, orange and lemon-flavored, cherry-flavored or lemon-flavored lollipop contains diclonine hydrochloride 2 mg, as well as appropriate flavorings and excipients (citric or tartaric acid, silicon dioxide, sucrose, mineral oil, dyes, etc.), in aluminum/polypropylene blister strips of 6 pcs., in a polypropylene box of 3 strips.

Fertility, pregnancy and lactation

Acceptable, but under the supervision of a doctor.

Nosological classification (ICD-10)

  • J02. 9 Acute pharyngitis, unspecified
  • J03. 9 Acute tonsillitis, unspecified (agranulocytic angina)
  • K05 Gingivitis and periodontal diseases
  • K12 Stomatitis and related lesions

Dosage (Posology) and method of administration

Inside (without swallowing, keep in the mouth until completely absorbed). Adults and children over 12 years of age - 1 lollipop every 2 hours (if necessary). The maximum daily dose is 8 lollipops per day.

ATC - Anatomical and therapeutic chemical classification

N01BX02 Deklein